XD-4000 series (Xcellsyz)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameXD-4000 series (Xcellsyz)
Drug Alias NameATP-competitive inhibitors (Xcellsyz)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinases inhibitorsRho-associated kinases inhibitors70-kDa ribosomal protein S6 kinases inhibitors
TargetsGlycogen synthase kinasesRho-associated kinases70-kDa ribosomal protein S6 kinases
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXcellsyz Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXcellsyz Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesCardiovascular DiseasesAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A